Gut Microbiota Modulation in GLP-1RA and SGLT-2i Therapy: Clinical Implications and Mechanistic Insights in Type 2 Diabetes

Gut Microbiota Modulation in GLP-1RA and SGLT-2i Therapy: Clinical Implications and Mechanistic Insights in Type 2 Diabetes | ReachRx